Zobrazeno 1 - 10
of 352
pro vyhledávání: '"G Schlimok"'
Autor:
M. E. Heim, Michael Koller, P. Bojko, E. Schneider, J. U. Rüffer, V. Milani, C. Riedner, P. Heußner, G. Schlimok, M. Besseler, N. Rinas, I. Fischer
Publikováno v:
Forum. 32:160-163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dced7dd73ab3350edf36d1ad779202f5
https://doi.org/10.1007/s12312-016-0206-6
https://doi.org/10.1007/s12312-016-0206-6
Autor:
E. Schneider, Michael Koller, M. E. Heim, C. Riedner, G. Schlimok, V. Milani, J. U. Rüffer, P. Bojko, P. Heußner, N. Rinas, M. Besseler, I. Fischer
Publikováno v:
Forum. 31:247-251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e87fa36e13f5abc7a3176e4eaf900c1
https://doi.org/10.1007/s12312-016-0068-y
https://doi.org/10.1007/s12312-016-0068-y
Publikováno v:
Zentralblatt für Chirurgie. 137:440-445
The understanding of hereditary vascular anomalies was hampered for a long time by unclear und unspecific terminology. Today, the classification of the International Society for the Study of Vascular Anomalies (ISSVA) differentiates between vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::236cde7f9b2da6159f94f306661dcb6a
https://doi.org/10.1055/s-0030-1262546
https://doi.org/10.1055/s-0030-1262546
Autor:
Bruno Märkl, Daniel Oruzio, Matthias Anthuber, G. Schlimok, Hendrik Jähnig, Robert A. Herrmann, Gerhard Schenkirsch, Hanno Spatz, Hans Arnholdt, Karlheinz Haude
Publikováno v:
Human Pathology. 41:1024-1033
Maspin has been characterized as a potent tumor suppressor in many in vitro and in vivo studies. In contrast, in stage III colon cancer, an association with shorter overall survival as well as sensitivity to chemotherapy was found for cases with nucl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4133a5b2b9f2b45d1b4a0167bc3963
https://doi.org/10.1016/j.humpath.2009.10.021
https://doi.org/10.1016/j.humpath.2009.10.021
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 111:1647-1650
Eine 21jahrige Patientin mit bilateralem lymphoblastischem Lymphom der Brustdruse wurde zytostatisch nach dem ALL/AUL-Protokoll in zwei Zyklen von je vierwochiger Dauer behandelt. Zusatzlich wurde eine Bestrahlungstherapie durchgefuhrt. Unter dem Ein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b197f24b0b4174b34aec402b2cd5dc6
https://doi.org/10.1055/s-2008-1068686
https://doi.org/10.1055/s-2008-1068686
Publikováno v:
TumorDiagnostik & Therapie. 28:141-145
PURPOSE: We examined how often ultrasound-guided core needle biopsies of lymph nodes yield subclassification of malignant lymphoma according to World Health Organization (WHO) criteria and help to avoid excisional biopsies. MATERIALS AND METHODS: The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3371be6942c10b8e22ea6d4d7c37c96
https://doi.org/10.1055/s-2007-963245
https://doi.org/10.1055/s-2007-963245
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 179:396-400
PURPOSE: We examined how often ultrasound-guided core needle biopsies of lymph nodes yield subclassification of malignant lymphoma according to World Health Organization (WHO) criteria and help to avoid excisional biopsies. MATERIALS AND METHODS: The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb211bf14406a994db960c8a2b0b2592
https://doi.org/10.1055/s-2007-962917
https://doi.org/10.1055/s-2007-962917
Publikováno v:
Bone marrow transplantation. 50(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19392c990dd12d95b7bcbabaf717b7ea
https://pubmed.ncbi.nlm.nih.gov/25581405
https://pubmed.ncbi.nlm.nih.gov/25581405
Autor:
Lothar Bergmann, G. Schlimok, Dieter Hoelzer, Walter Fiedler, Hartmut Kirchner, Aruna Raghavachar, Lucien Noens, Arnold Ganser, Jürgen Krauter, Michael Lübbert, Renate Arnold, Gerhard Heil
Publikováno v:
Annals of Hematology. 83:336-344
We treated 305 de novo acute myeloid leukemia (AML) patients aged/=60 years with risk-adapted therapy. Patients with CBF leukemias or normal karyotype and good response to induction I [/=5% bone marrow (BM) blasts on day 15] were considered standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4e0cd31dd23fbd764b279b27257515
https://doi.org/10.1007/s00277-004-0853-z
https://doi.org/10.1007/s00277-004-0853-z
Autor:
N Kröger, Lorenz Trümper, S Hegewisch-Becker, A R Zander, P. Müller, C. F. Hess, W. Budach, C Meisner, B Wörmann, D. K. Hossfeld, Bernd Hertenstein, H. Einsele, C Straka, Holger Hebart, Michael Bamberg, William I. Bensinger, Lothar Kanz, H. Schmidt, G. Schlimok, Dietrich Peest, Norbert Frickhofen, H. Schmidberger, Bernd Metzner
Publikováno v:
Bone Marrow Transplantation. 32:593-599
The overall survival of patients with advanced multiple myeloma (MM) undergoing high-dose chemotherapy and autologous stem cell transplantation (SCT) depends mainly on the quality of response. Thus, to improve the response rate, a new intensified hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de1fc0cc59818d1fa0a7b6a9a92d99d2
https://doi.org/10.1038/sj.bmt.1704192
https://doi.org/10.1038/sj.bmt.1704192